相关实验视频

Updated: Jul 26, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

[中国非小细胞肺癌与EGFR外基因组20插入突变 (2023年版) 专家共识]

    Zhongguo fei ai za zhi = Chinese journal of lung cancer
    |June 14, 2023
    PubMed
    概括

    在非小细胞肺癌 (NSCLC) 中,表皮生长因子受体 (EGFR) 插入20个外显子 (ex20ins) 突变是罕见的,但具有攻击性. 这一共识为诊断,治疗和测试这些具有挑战性的突变提供了指导.

    关键词:
    达成共识 达成共识皮表皮生长因子受体前20插入突变突变.肺部瘤是什么 肺部瘤

    更多相关视频

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    24.4K
    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

    Published on: August 11, 2017

    8.9K

    相关概念视频

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.7K